InvestorsHub Logo
Followers 233
Posts 26887
Boards Moderated 0
Alias Born 01/12/2013

Re: None

Wednesday, 06/26/2013 7:49:16 AM

Wednesday, June 26, 2013 7:49:16 AM

Post# of 428665
Open Letter to John Fuson, former Associate Chief Counsel at the FDA.

Law Clerk
The Hon. Marsh S Berzon, US Court of Appeals May 2000-June 2001

Associate
Covington & Burling Oct 2001 - Nov 2007

Associate Chief Counsel Nov 2007 - May 2012

Partner
Crowell & Moring LLP May 2012 - present

--Drafted "The Citizen Petition" to change the OB listing for Lovaza's active ingredients Feb 2013, shortly BEFORE MAPP policy 5021.1.

===========
Just a few questions:

Who hired Crowell & Moring to draft the petition?

Did you know about MAPP 5021.1 before it was posted at the FDA?
If yes, who told you?

How much did you know about Vascepa's exclusivity before May 2012?
===========

Congratulations on your new Partnership at Crowell & Moring,

Amarin investors

jfuson@crowell.com
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News